Arcutis Biotherapeutics, Inc. (ARQT)
24.79
-0.29
(-1.16%)
USD |
NASDAQ |
Aug 24, 16:00
24.79
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Debt to Equity Ratio : 0.5174 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.5174 |
| March 31, 2026 | 0.6047 |
| December 31, 2025 | 0.6028 |
| September 30, 2025 | 0.7198 |
| June 30, 2025 | 0.7927 |
| March 31, 2025 | 0.7767 |
| December 31, 2024 | 0.7019 |
| September 30, 2024 | 1.329 |
| June 30, 2024 | 1.113 |
| March 31, 2024 | 0.9191 |
| December 31, 2023 | 2.322 |
| September 30, 2023 | 4.390 |
| June 30, 2023 | 2.537 |
| March 31, 2023 | 1.456 |
| December 31, 2022 | 0.9664 |
| September 30, 2022 | 0.7448 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.4001 |
| March 31, 2022 | 0.3068 |
| December 31, 2021 | 0.2605 |
| September 30, 2021 | 0.0144 |
| June 30, 2021 | 0.0124 |
| March 31, 2021 | 0.0112 |
| December 31, 2020 | 0.0183 |
| September 30, 2020 | 0.0214 |
| June 30, 2020 | 0.0177 |
| March 31, 2020 | 0.0011 |
| December 31, 2019 | 0.003 |
| September 30, 2019 | 0.018 |
| June 30, 2019 | 0.0116 |
| March 31, 2019 | |
| December 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Insmed, Inc. | 0.9865 |
| Emergent BioSolutions, Inc. | 1.723 |
| Exelixis, Inc. | 0.09 |
| Vertex Pharmaceuticals, Inc. | 0.0977 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 488.54M |
| Total Liabilities (Quarterly) | 267.96M |
| Shareholders Equity (Quarterly) | 220.58M |
| Current Ratio | 2.917 |
| Net Debt Paydown Yield | -0.02% |